Closed
14.3 1.13
24h
Min
14.18
Max
14.3
Income | 68M 55M |
|---|---|
Sales | 11M 26M |
P/E Sector Avg | 59.625 37.461 |
Profit margin | 209.334 |
Employees | 97 |
EBITDA | 87M 75M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +40.06% upside |
Next Earnings | 12 lis 2025 |
|---|
Market Cap | 151M 721M |
|---|---|
Previous open | 13.17 |
Previous close | 14.3 |
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 20 USD 40.06%
High 28 USD
Low 13 USD
Based on 6 Wall Street analysts offering 12 month price targets forTheravance Biopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$